MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates

Journal of Magnetic Resonance Imaging

Volumn 40, Issue 3, 2014, Pages 691-697

  Nakajima, Takahito ^a   Turkbey, Baris ^a   Sano, Kohei ^a   Sato, Kazuhide ^a   Bernardo, Marcelino ^b   Hoyt, Robert F ^c   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

contrast agents; Gadofosveset; lymphatic drainage; MR lymphangiography; sentinel lymph node

Indexed keywords

DENDRIMER; GADOFOSVESET; HUMAN SERUM ALBUMIN; CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM PENTETATE; ORGANOMETALLIC COMPOUND; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; LYMPH NODE; LYMPHANGIOGRAPHY; LYMPHATIC DRAINAGE; MACROMOLECULE; MAGNETIC RESONANCE LYMPHANGIOGRAPHY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIMATE; PRIORITY JOURNAL; SQUIRREL MONKEY; ANATOMY AND HISTOLOGY; ANIMAL; HUMAN; INTRADERMAL DRUG ADMINISTRATION; NUDE MOUSE; PROCEDURES; SIGNAL NOISE RATIO;

ANIMALS; CONTRAST MEDIA; DENDRIMERS; GADOLINIUM; GADOLINIUM DTPA; HUMANS; INJECTIONS, INTRADERMAL; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; ORGANOMETALLIC COMPOUNDS; SAIMIRI; SERUM ALBUMIN; SIGNAL-TO-NOISE RATIO;

EID: 84906092094     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24395     Document Type: Article

References (30)

1. Suga K, Shimizu K, Kawakami Y, et al. Lymphatic drainage from esophagogastric tract: feasibility of endoscopic CT lymphography for direct visualization of pathways. Radiology 2005; 237: 952-960.
2. Suga K, Yuan Y, Okada M, et al. Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience. Radiology 2004; 230: 543-552.
3. Minato M, Hirose C, Sasa M, Nishitani H, Hirose Y, Morimoto T,. 3-Dimensional computed tomography lymphography-guided identification of sentinel lymph nodes in breast cancer patients using subcutaneous injection of nonionic contrast medium: a clinical trial. J Comput Assist Tomogr 2004; 28: 46-51.
4. Misselwitz B,. MR contrast agents in lymph node imaging. Eur J Radiol 2006; 58: 375-382.
5. Notohamiprodjo M, Weiss M,. MR lymphangiography at 3.0 T: correlation with Lymphoscintigraphy. Radiology 2012; 264: 78-87.
6. Hama Y, Bernardo M, Regino CAS, et al. MR lymphangiography using dendrimer-based contrast agents: a comparison at 1.5T and 3.0T. Magn Reson Med 2007; 57: 431-436.
7. Kobayashi H, Kawamoto S, Sakai Y, et al. Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst 2004; 96: 703-708.
8. Sena LM, Fishman SJ, Jenkins KJ, et al. Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models. Nanomedicine 2010; 5: 1183-1191.
9. Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW,. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res 2003; 63: 271-276.
10. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-2499.
11. Quon A, Gambhir SS,. FDG-PET and beyond: molecular breast cancer imaging. J Clin Oncol 2005; 23: 1664-1673.
12. Veronesi U, De Cicco C, Galimberti VE, et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 2007; 18: 473-478.
13. Zornoza G, Garcia-Velloso MJ, Sola J, Regueira FM, Pina L, Beorlegui C,. 18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer. Eur J Surg Oncol 2004; 30: 15-19.
14. Wagner JD, Schauwecker D, Davidson D, et al. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma. Cancer 2005; 104: 570-579.
15. Lucarelli RT, Ogawa M, Kosaka N, Turkbey B, Kobayashi H, Choyke PL,. New approaches to lymphatic imaging. Lymphat Res Biol 2009; 7: 205-214.
16. Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL,. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release 2006; 111: 343-351.
17. Barrett T, Kobayashi H, Brechbiel M, Choyke PL,. Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur J Radiol 2006; 60: 353-366.
18. Kobayashi H, Brechbiel MW,. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 2005; 57: 2271-2286.
19. Grist T, Korosec F, Peters D,. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998; 207: 539-544.
20. Lauffer R, Parmelee D, Dunham S,. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998; 207: 529-538.
21. Lauffer RB, Parmelee DJ, Ouellet HS, et al. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol 1996;(Suppl 2): S356-S358.
22. Yang M, Hoppmann S, Chen L, Cheng Z,. Human serum albumin conjugated biomolecules for cancer molecular imaging. Curr Pharm Des 2012; 18: 1023-1031.
23. Caravan P, Cloutier NJ, Greenfield MT, et al. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc 2002; 124: 3152-3162.
24. Normal M-C, Herborn CU, Lauenstein TC, et al. Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model. AJR Am J Roentgenol 2002; 179: 1567-1572.
25. Caravan P, Parigi G, Chasse JM, et al. Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. Inorg Chem 2007; 46: 6632-6639.
26. Fasano M, Curry S, Terreno E, et al. The extraordinary ligand binding properties of human serum albumin. IUBMB life 2005; 57: 787-796.
27. Kobayashi H, Kawamoto S, Jo S-K, Bryant HL, Brechbiel MW, Star RA,. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug Chem 2003; 14: 388-394.
28. Kobayashi H, Sato N, Hiraga A, et al. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties. Magn Reson Med 2001; 45: 454-460.
29. Longmire MR, Ogawa M, Choyke PL, Kobayashi H,. Biologically optimized nano-sized molecules and particles: more than just size. Bioconjug Chem 2011; 22: 993-1000.
30. Kobayashi H, Brechbiel MW,. Dendrimer-based nanosized MRI contrast agents. Curr Pharm Biotechnol 2004; 5: 539-549.